Ardelyx stock tumbles as lawsuit against CMS dismissed over Xphozah

Update 12:40pm: Updates shares, adds Ardelyx response.

Ardelyx (NASDAQ:ARDX) plunged 21% after a court dismissed a lawsuit and denied a preliminary injunction after the company filed a lawsuit in July against the Centers for Medicare and Medicaid Services (CMS